Talaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $43,693.30 in Stock

Talaris Therapeutics, Inc. (NASDAQ:TALS – Get Rating) Director Suzanne Ildstad sold 16,870 shares of the company’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $2.59, for a total value of $43,693.30. Following the transaction, the director now directly owns 3,798,542 shares of the company’s stock, valued […]

Related Keywords

United States ,Suzanne Ildstad ,Nasdaq ,Morgan Stanley ,York Mellon Corp ,Securities Exchange Commission ,Blackrock Inc ,Talaris Therapeutics Inc ,Charles Schwab Investment Management Inc ,Jpmorgan Chase Co ,Talaris Therapeutics ,Get Rating ,Director Suzanne Ildstad ,Exchange Commission ,New York Mellon Corp ,Schwab Investment Management ,State Street Corp ,Street Corp ,Talaris Therapeutics Daily ,